Paradox India Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 27-12-2024
- Paid Up Capital ₹ 0.86 M
as on 27-12-2024
- Company Age 25 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 M
as on 27-12-2024
- Revenue %
(FY 2014)
- Profit 7.15%
(FY 2014)
- Ebitda
- Net Worth 1.75%
(FY 2014)
- Total Assets 7.27%
(FY 2014)
About Paradox India Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.86 M.
The company currently has active open charges totaling ₹1.20 M.
Dipendra Roy and Nandini Roy serve as directors at the Company.
- CIN/LLPIN
U45202WB1999PTC088737
- Company No.
088737
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Midnapore, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Paradox India Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dipendra Roy  | Director | 02-Feb-1999 | Current |
| Nandini Roy | Director | 10-Jul-2003 | Current |
Financial Performance of Paradox India Pharmaceuticals.
Paradox India Pharmaceuticals Private Limited, for the financial year ended 2014, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 7.15% increase in profit. The company's net worth moved up by a moderate rise of 1.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Paradox India Pharmaceuticals?
In 2017, Paradox India Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Oct 2007 | ₹1.20 M | Open |
How Many Employees Work at Paradox India Pharmaceuticals?
Unlock and access historical data on people associated with Paradox India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paradox India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paradox India Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
